Skip to main content
SpringerLink
Log in

Perspektiven und Forschungspotenziale: COPD

  • Chapter
Volkskrankheit Asthma/COPD

  • 2462 Accesses

Zusammenfassung

Die chronisch-obstruktive Bronchitis und das Lungenemphysem (“chronic obstructive pulmonary disease”; COPD) sind Erkrankungen, die mit einer nicht vollständig reversiblen Verminderung des Atemflusses einhergehen. Die Krankheiten sind üblicherweise progredient und mit einer abnormen Entzündungsreaktion der Lunge auf schädliche Gase und Partikel verbunden. Diese sind in erster Linie durch das Zigarettenrauchen verursacht. Die COPD betrifft primär die Lunge, sie hat aber auch klinisch bedeutsame systemische Konsequenzen. Die Begriff sbestimmung ist international akzeptiert und in die nationalen Leitlinien übernommen worden [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932–46.

    Article  CAS  PubMed  Google Scholar 

  2. Worth H, Buhl R, Cegla U, Criee CP, Gillissen A, Kardos P, Kohler D, Magnussen H, Meister R, Nowak D, Petro W, Rabe KF, Schultze-Werninghaus G, Sitter H, Teschler H, Welte T, Wettengel R. [Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur pneumologie]. Pneumologie 2002;56:704–38.

    Article  CAS  PubMed  Google Scholar 

  3. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis; Management, and Prevention of Chronic Obstructive Pulmonary Disease NHLBI/WHO Workshop Report. NIH Publication 2701. 2001. http://www.gold.com accessed November 22 2006.

    Google Scholar 

  4. Nowak D, Dietrich ES, Oberender P, Uberla K, Reitberger U, Schlegel C, Albers F, Ruckdaschel S, Welsch R. [Cost-of-illness Study for the Treatment of COPD in Germany]. Pneumologie 2004;58:837–44.

    Article  CAS  PubMed  Google Scholar 

  5. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7:725–9.

    Article  CAS  PubMed  Google Scholar 

  6. Celli BR, Cote CG, Marin JM, Casanova C, Montes DO, Mendez RA, Pinto PV, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J Med 2004;350:1005–12.

    Article  CAS  PubMed  Google Scholar 

  7. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005;26:630–6.

    Article  CAS  PubMed  Google Scholar 

  8. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005;128:3810–6.

    Article  PubMed  Google Scholar 

  9. Imfeld S, Bloch KE, Weder W, Russi EW. The BODE index after lung volume reduction surgery correlates with survival. Chest 2006;129:873–8.

    Article  PubMed  Google Scholar 

  10. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61:17–22.

    Article  CAS  PubMed  Google Scholar 

  11. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245–57.

    Article  CAS  PubMed  Google Scholar 

  12. Watz H, Magnussen H. [Comorbidities of COPD.]. Internist (Berl) 2006;47:895–900.

    Article  CAS  Google Scholar 

  13. Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc.Am Thorac.Soc. 2006;3:687–90.

    Article  CAS  PubMed  Google Scholar 

  14. Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc.Am Thorac.Soc. 2006;3:703–8.

    Article  CAS  PubMed  Google Scholar 

  15. Muller KC, Welker L, Paasch K, Feindt B, Erpenbeck VJ, Hohlfeld JM, Krug N, Nakashima M, Branscheid D, Magnussen H, Jorres RA, Holz O. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir Res. 2006;7:32.

    Article  PubMed  Google Scholar 

  16. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat.Med. 1997;3:675–7.

    Article  CAS  PubMed  Google Scholar 

  17. O’Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832–40.

    Article  PubMed  Google Scholar 

  18. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jorres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am.J Respir Crit Care Med. 2000;162:216–20.

    CAS  PubMed  Google Scholar 

  19. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006;119:21–31.

    Article  PubMed  Google Scholar 

  20. Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 2006;174:853–7.

    Article  PubMed  Google Scholar 

  21. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–7.

    Article  PubMed  Google Scholar 

  22. Nici L, Donner C, Wouters E, ZuWallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390–413.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Krankenhaus Großhansdorf Zentrum für Pneumologie und Thoraxchirurgie Lehrstuhl für Innere Medizin-Pneumologie, Schleswig-Holstein Universität, Campus Lübeck, Wöhrendamm 80

    Prof. Dr. Helgo Magnussen

Authors
  1. Prof. Dr. Helgo Magnussen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover

    Heidrun Lingner  & Friedrich-Wilhelm Schwartz  & 

  2. Fachklinik Allgäu, Peter-Heel-Straße 29, 87459, Pfronten-Ried

    Konrad Schultz

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Magnussen, H. (2007). Perspektiven und Forschungspotenziale: COPD. In: Lingner, H., Schwartz, FW., Schultz, K. (eds) Volkskrankheit Asthma/COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70920-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-70920-6_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-70919-0

  • Online ISBN: 978-3-540-70920-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation